Skip to main content
Fig. 2 | BMC Infectious Diseases

Fig. 2

From: Antiviral mechanism of carvacrol on HSV-2 infectivity through inhibition of RIP3-mediated programmed cell necrosis pathway and ubiquitin-proteasome system in BSC-1 cells

Fig. 2

The dose-response curves of carvacrol and 2% true carvacrol solution against HSV-2 in different modes. (A, B, C) carvacrol; (D, E, F) 2% true carvacrol solution; (a) pre-treatment; (b) treatment; (c) direct inactivation. The effects of carvacrol on HSV-2 virus release. (G) the viral titers of culture supernatant and intracellular virus; (H) the viral release rate of HSV-2. (I) The effect of delay addition and early removal of 0.5 mmol/L carvacrol on viral titer (MOI = 0.00025). *, p<0.05; **, p < 0.01

Back to article page

BMC Infectious Diseases

ISSN: 1471-2334

Contact us